About Us - Board of Directors

Joseph F. Lovett (Chairman)

Joe Lovett is managing general partner at Louisiana Fund I. Mr. Lovett serves as Chairman of the Board of Esperance Pharmaceuticals, Inc. He has over 36 years of experience in the life science field and has extensive experience managing venture capital funds. He holds a B.A in economics from the University of Vermont and an MBA from California State Polytechnic University.

Ross P. Barrett

Ross Barrett is managing general partner at Themelios Venture Partners and is also a Partner at VCE Capital. His expertise includes risk assessment and regulatory reform. Mr. Barrett received a B.A. in Political Science from Southern Methodist University, and a J.D. from Louisiana State University School of Law. He also earned a masters degree in taxation from New York University School of Law.

Chad Souvignier, Ph.D.

Chad Souvignier is Managing Director at Research Corporation Technologies. Dr. Souvignier conducts the scientific and business analysis of early-stage biomedical investment opportunities and manages a portfolio of projects and investments. He earned a B.S. in Chemistry from the University of Wisconsin, a M.S. in Polymer Science from the University of Akron, a M.B.A. and Ph.D. in Materials Science and Engineering from the University of Arizona.

Hector Alila, Ph.D.

Hector Alila is Founder, President, and C.E.O of Esperance Pharmaceuticals. Dr. Alila is a biopharmaceutical industry veteran bringing over 20 years of management, drug development, and research experience in large pharmaceutical and biotech industry to Esperance. He served as Senior Vice President of Drug Development at Protalex, Inc. (New Hope, PA), Vice President of Product Development at Cell Pathways, Inc. in Horsham, PA, (later acquired by OSI Pharmaceuticals), Director of Biology/Pharmacology at GeneMedicine, Inc. in The Woodlands, TX,  (which merged with Megabios to become Valentis Inc.) and several research, development, and management positions at SmithKline Beecham (now GlaxoSmithKline) in PA. He obtained his Ph.D. degree in physiology and immunology from Cornell University (Ithaca, NY).